Barrios Carlos, Sánchez-Vanegas Guillermo, Villarreal-Garza Cynthia, Ossa Andrés, Lombana Milton A, Monterrosa-Blanco Angélica, Ferrigno Ana S, Castro Carlos Alberto
Oncoclinicas Group, Oncology Research Center, Hospital São Lucas, PUCRS Latin-American Cooperative Oncology Group (LACOG), Rio Grande do Sul, RS, Brazil.
Soluciones Integrales Para la Investigación y la Educación en Salud - SIIES Consultores, Cr 45ª #106ª-20, Bogotá, Cundinamarca, Colombia.
Lancet Reg Health Am. 2022 Apr 7;11:100254. doi: 10.1016/j.lana.2022.100254. eCollection 2022 Jul.
Multidisciplinary care (MDC) remains a cornerstone for breast cancer management as it is associated with improved quality of care and patient outcomes. However, the adoption of MDC practice is heterogeneous and has been poorly explored in Latin America. The objective was to describe barriers and possible facilitators for providing MDC to breast cancer patients in five Latin American countries.
A panel of experts with an active clinical practice in Bolivia, Colombia, Ecuador, Mexico, and Uruguay was convened to identify barriers and facilitators to MDC. This study is a qualitative synthesis of a structured discussion regarding the state of MDC in the setting of breast cancer.
Experts recognized that most oncology practices in Latin America do not apply a multidisciplinary approach for breast cancer patients. Predominant barriers for MDC are fragmentation of health services, being understaffed, inadequate infrastructure, and geographic disparities. Access to MDC varies widely in the region, with significant heterogeneity documented within countries. MDC practice was described as being more common in the private sector in Ecuador and Uruguay, while it is more widely implemented in public institutions of Colombia and Bolivia.
Establishing quality MDC remains a challenge for oncology practices in Latin America. Addressing regional issues and identifying specific local needs is warranted to encourage the adoption of an effective multidisciplinary approach and, consequently, improve clinical outcomes. Active involvement of all stakeholders is required to build locally solutions and should involve institutions, health professionals, and patients.
Research was funded by Productos Roche S.A.
多学科护理(MDC)仍然是乳腺癌管理的基石,因为它与改善护理质量和患者预后相关。然而,MDC实践的采用情况参差不齐,在拉丁美洲尚未得到充分探索。目的是描述在五个拉丁美洲国家为乳腺癌患者提供MDC的障碍和可能的促进因素。
召集了一个在玻利维亚、哥伦比亚、厄瓜多尔、墨西哥和乌拉圭积极从事临床实践的专家小组,以确定MDC的障碍和促进因素。本研究是对关于乳腺癌背景下MDC状况的结构化讨论的定性综合。
专家们认识到,拉丁美洲的大多数肿瘤学实践并未对乳腺癌患者采用多学科方法。MDC的主要障碍包括卫生服务碎片化、人员配备不足、基础设施不完善以及地理差异。该地区获得MDC的机会差异很大,各国均记录到显著的异质性。在厄瓜多尔和乌拉圭,MDC实践在私营部门更为常见,而在哥伦比亚和玻利维亚的公共机构中实施得更为广泛。
建立高质量的MDC对拉丁美洲的肿瘤学实践仍然是一项挑战。解决区域问题并确定具体的当地需求,对于鼓励采用有效的多学科方法并进而改善临床结果是必要的。需要所有利益相关者的积极参与来构建本地化解决方案,这应该包括机构、卫生专业人员和患者。
研究由罗氏产品有限公司资助。